Brief: Janux Therapeutics Reports Third Quarter 2022 Financial Results, Business Highlights

Janux Therapeutics

10/11/2022 21:41

Nov 10 (Reuters) - Janux Therapeutics Inc  JANX.O :
    * JANUX THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND BUSINESS HIGHLIGHTS
    * JANUX THERAPEUTICS INC QTRLY LOSS PER SHARE $0.40

Source text for Eikon:  ID:nBw3n3RT6a 
Further company coverage:  JANX.O 
 ((Reuters.Briefs@thomsonreuters.com;))